Hanmi Pharm. Co., Ltd. (128940.KS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Hanmi Pharm. Co., Ltd., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 33.80x |
| P/B Ratio | 4.63x |
| P/S Ratio | 3.74x |
| Profitability | |
| Gross Margin | 57.1% |
| Operating Margin | 14.5% |
| Net Margin | 11.0% |
| EBITDA Margin | 20.9% |
| Liquidity | |
| Current Ratio | 1.51x |
| Quick Ratio | 0.95x |
| Leverage | |
| Debt/Equity | 0.35x |
YoY = year-over-year change. Source: FMP..